MED financial statements and SEC filings

MED annual income statement

Fiscal period endRevenueOperating incomeNet incomeSEC filing
2025-12-31$385.79M-$14.21M-$18.67M10-K
2024-12-31$602.46M$2.88M$2.09M10-K
2023-12-31$1.07B$126.40M$99.42M10-K
2022-12-31$1.60B$184.81M$143.57M10-K
2021-12-31$1.53B$216.24M$164.03M10-K
2020-12-31$934.84M$134.16M$102.86M10-K

MED annual balance sheet

Fiscal period endAssetsLiabilitiesEquitySEC filing
2025-12-31$247.97M$49.05M$198.92M10-Q
2024-12-31$284.21M$74.10M$210.11M10-K
2023-12-31$309.91M$108.43M$201.48M10-K
2022-12-31$316.21M$161.17M$155.04M10-K
2021-12-31$398.33M$195.85M$202.47M10-K
2020-12-31$276.08M$118.84M$157.25M10-K

MED annual cash flow

Fiscal period endOperating cash flowCapital expenditureFinancing cash flowSEC filing
2025-12-31$6.86M-$5.61M-$564.00K10-K
2024-12-31$24.48M-$7.45M-$1.51M10-K
2023-12-31$147.66M-$6.48M-$79.79M10-K
2022-12-31$194.57M-$16.68M-$199.58M10-K
2021-12-31$94.55M-$34.21M-$125.13M10-K
2020-12-31$145.20M-$5.89M-$57.14M10-K